Advancing data and artificial intelligence - AstraZeneca

Advancing data and artificial intelligence  AstraZeneca

FLUMIST® (Influenza, Vaccine Live, Intranasal), the nation’s only nasal spray flu vaccine, now av...

FLUMIST® (Influenza, Vaccine Live, Intranasal), the nation’s only nasal spray flu vaccine, now available for home delivery  AstraZeneca US

Pharmaceuticals in the environment - AstraZeneca

Pharmaceuticals in the environment  AstraZeneca

North Korean hackers suspected of targeting vaccine maker AstraZeneca in cyberattack, Reuters rep...

North Korean hackers suspected of targeting vaccine maker AstraZeneca in cyberattack, Reuters reports  CNN

Graphs in Healthcare: Improving Patient Outcomes with Graph Algorithms - Neo4j

Graphs in Healthcare: Improving Patient Outcomes with Graph Algorithms  Neo4j

AstraZeneca drafts plan to spin off China business amid tensions - Financial Times

AstraZeneca drafts plan to spin off China business amid tensions  Financial Times

At the forefront of lung cancer treatment - AstraZeneca

At the forefront of lung cancer treatment  AstraZeneca

Renal - AstraZeneca

Renal  AstraZeneca

Medicines - Our focus areas - AstraZeneca

Medicines - Our focus areas  AstraZeneca

Information for suppliers - AstraZeneca

Information for suppliers  AstraZeneca

Leading the revolution in pancreatic cancer - AstraZeneca

Leading the revolution in pancreatic cancer  AstraZeneca

Coronavirus (COVID-19) information & research hub - AstraZeneca

Coronavirus (COVID-19) information & research hub  AstraZeneca

Saudi Arabia - AstraZeneca

Saudi Arabia  AstraZeneca

Medicines: Oncology Portfolio and Pipeline - AstraZeneca

Medicines: Oncology Portfolio and Pipeline  AstraZeneca

Oncology – AstraZeneca - Redefining Cancer Care - AstraZeneca

Oncology – AstraZeneca - Redefining Cancer Care  AstraZeneca

Vaccines and Immune Therapies - AstraZeneca

Vaccines and Immune Therapies  AstraZeneca

Brilinta significantly reduced the rate of the composite of stroke and death in patients who had ...

Brilinta significantly reduced the rate of the composite of stroke and death in patients who had an acute ischaemic stroke or transient ischaemic attack in the Phase III THALES trial  AstraZeneca

Transforming long-term outcomes in prostate cancer - AstraZeneca

Transforming long-term outcomes in prostate cancer  AstraZeneca

About Our Company - AstraZeneca

About Our Company  AstraZeneca